Indications and uses
Use on affected areas in place of your regular soap and shampoo for relief of itching, irritation, redness, flaking and scaling associated with eczema and psoriasis.
Use on affected areas in place of your regular soap and shampoo for relief of itching, irritation, redness, flaking and scaling associated with eczema and psoriasis.
Use in place of soap to cleanse and soothe the skin Rinse off with plenty of water The smallest effective dose should be used Avoid very hot water
Store between 50°- 86°F.
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Borax (20 X H.P.U.S. 0.2%)* | Eczema & Psoriasis Relief |
| Graphites (6 X H.P.U.S. 0.2%)* | Eczema & Psoriasis Relief |
| Kalium Sulphuricum (3 X H.P.U.S.0.2%)* | Eczema & Psoriasis Relief |
| Natrum Muriaticum (12 X H.P.U.S.0.2%)* | Eczema & Psoriasis Relief |
* The letters H.P.U.S. indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
For external use only.
Keep out of the reach of children.
Store between 50°- 86°F.
Aloe Vera, Bergamot Oil, Calendula Officinalis, Citric Acid, Cocamidopropyl Betaine, Decyl Glucoside, Diazolidinylurea, Lauryl Glucoside, Lavandula Angustifolia, Matricaria Chamomilla, PEG-120 Methyl Glucose Dioleate, Phenoxyethanol, Sodium Cocoamphoacetate, Sodium Lauroyl Sarcosinate, Water
Call Toll Free 1-877- 687-2542
usainfo@natralia.com
www.natralia.com
NDC: 43251-2281-1
natralia™
NATURALLY AUSTRALIAN
Eczema &
Psoriasis Wash
& Shampoo
SOAP FREE
Proud Supporter
eczema
association
australasia
eaa
SUITABLE FOR CHILDREN
Homeopathic
Net Wt 7 oz (200 mL)
383FL-8

| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Graphite | ACTIVE INGREDIENT | 4QQN74LH4O | 4 | |
| Potassium Sulfate | ACTIVE INGREDIENT | 1K573LC5TV | 4 | |
| Sodium Borate | ACTIVE INGREDIENT | 91MBZ8H3QO | 4 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 4 | |
| Borate Ion | ACTIVE MOIETY | 44OAE30D22 | 4 | |
| Graphite | ACTIVE MOIETY | 4QQN74LH4O | 4 | |
| Sodium Cation | ACTIVE MOIETY | LYR4M0NH37 | 4 | |
| Sulfate Ion | ACTIVE MOIETY | 7IS9N8KPMG | 4 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 4 | |
| Bergamot Oil | INACTIVE INGREDIENT | 39W1PKE3JI | 4 | |
| Calendula Officinalis Flower | INACTIVE INGREDIENT | P0M7O4Y7YD | 4 | |
| Chamomile | INACTIVE INGREDIENT | FGL3685T2X | 4 | |
| Citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 4 | |
| Cocamidopropyl Betaine | INACTIVE INGREDIENT | 5OCF3O11KX | 4 | |
| Decyl glucoside | INACTIVE INGREDIENT | Z17H97EA6Y | 4 | |
| Diazolidinyl urea | INACTIVE INGREDIENT | H5RIZ3MPW4 | 4 | |
| Lauryl glucoside | INACTIVE INGREDIENT | 76LN7P7UCU | 4 | |
| Lavender Oil | INACTIVE INGREDIENT | ZBP1YXW0H8 | 4 | |
| PEG-120 Methyl glucose dioleate | INACTIVE INGREDIENT | YM0K64F20V | 4 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 4 | |
| Sodium Cocoamphoacetate | INACTIVE INGREDIENT | W7Q5E87674 | 4 | |
| Sodium Lauroyl Sarcosinate | INACTIVE INGREDIENT | 632GS99618 | 4 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43251-2281 | 43251-2281-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| Diazolidinyl urea | DIAZOLIDINYL UREA | H5RIZ3MPW4 | OINTMENT / TOPICAL | 0.1 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| Sodium Lauroyl Sarcosinate | SODIUM LAUROYL SARCOSINATE | 632GS99618 | SHAMPOO / TOPICAL | 12.5 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| Diazolidinyl urea | DIAZOLIDINYL UREA | H5RIZ3MPW4 | CREAM / TOPICAL | 29 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, COATED / ORAL | NA | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| Lavender Oil | LAVENDER OIL | ZBP1YXW0H8 | GEL / TOPICAL | 0.1 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| Diazolidinyl urea | DIAZOLIDINYL UREA | H5RIZ3MPW4 | LOTION / TOPICAL | 3 %w/w | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INHALANT / RESPIRATORY (INHALATION) | NA | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| Citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e8fe71f0-8778-410f-b5f7-3c8e4cf9567b | fb7be5dc-3d93-441b-860a-a2caa5cacb70 | 2020-12-15 | Warnings | e8fe71f0-8778-410f-b5f7-3c8e4cf9567b fb7be5dc-3d93-441b-860a-a2caa5cacb70 |
Adverse event summaries are temporarily unavailable. Other product information remains available.